Protara Therapeutics, Inc. — Director's Dealing 2015

Jul 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2015-07-21

Reporting Person: Canute Scott A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-21	Stock Option (Right to Buy)	$18.25	A	13333	Acquired	2025-07-21	Common Stock, $0.001 par value (13333)	Direct

Footnotes

F1: The options were granted on July 21, 2015 and will vest annually over a three-year period measured from the date of grant.